Another Eylea threat: Roche expands label for blockbuster eye drug Vabysmo
With hopes of dethroning Regeneron’s blockbuster eye drug franchise Eylea, Roche on Thursday announced the FDA has expanded the label of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
